←
Manya Angley2,385 posts
Manya Angley avatar

Manya Angley

@ManyaAngley

Advanced Practice Pharmacist, General Practice, Aged Care & Disability Pharmacist, Researcher & Consultant (She/Her)

◷ Joined October 2014▧ 173 Photos and videos
Manya Angley avatar
Manya Angley@ManyaAngley·Jul 19

Grateful for the opportunity to be interviewed by @BenchSideStory to discuss my clinical and research endeavours to improve medicines safety at transitions of care - especially for people living with #intellectualdisability and #autismspectrumdisorder #QUM #transitionsofcare

MEDICATION MANAGEMENT AND QUALITY USE OF MEDICINES Dr Manya Angley, Adjunct Professor, School of Health and Clinical Sciences, Health Professions Education, University of Western Australia & Director, Manya Angley Research and Consulting (MARAC), Adelaide, South Australia RESEARCHER PROFILE Filmed in Adelaide, Australia | July 2026 Adjunct Professor Manya Angley is an Advanced Practice Pharmacist. Manya spent the first 20 years of her career as a teaching and research academic at the University of South Australia. She currently works as a credentialed pharmacist and researcher through her business, Manya Angley Research and Consulting (MARAC). Her professional activities are focused in general practice, disability and aged care. She continues to undertake research in medicines safety at care transitions and quality use of medicines in the aged care and disability sectors. Manya has just stepped down as SA/NT Branch President of the Pharmaceutical Society of Australia (July 2023-June 2026) was previously vice-president (2022-2023). Manya was the proud recipient of the Pharmaceutical Society of Australia (SA/NT Branch) Pharmacist of the Year (2021) and the Australian Association of Consultant Pharmacy MIMS Consultant Pharmacist of the Year (2021). Manya holds, or has held, positions on various multidisciplinary Department of Health, Disability and Ageing (DoHDA) and the ACSQHC technical expert committees. She is regularly invited to present at National pharmacy conferences and to present to other disciplines. Manya was appointed an Adjunct Professor at the University of Western Australia in 2025. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

10:47
Shania Liu avatar
⟳ Manya Angley retweeted
Shania Liu@ShaniaLiu_·15 Oct 2024

Great podcast episode on safe #medication #management during #transitions of care by @elliott_rohan & @Deequm Full paper: doi.org/10.18773/austprescr.… @AdPhaAU @JonPenm @ManyaAngley

New #AustralianPrescriber #podcast episode is out now. Transitions of care from hospital can be hazardous. Hear from complex care coordinator Deirdre Criddle and senior pharmacist Rohan Elliott on safe medication management during transitions of care from hospital. Listen now: buff.ly/3zN4oNZ @Deequm @elliott_rohan #medicinesstewardship #medicationmanagement #transitionsofcare #Australia

0:40
Jonathan Penm, PhD, FFIP FAdPha FPS FANZCAP FHEA avatar
⟳ Manya Angley retweeted
Jonathan Penm, PhD, FFIP FAdPha FPS FANZCAP FHEA@JonPenm·23 Aug 2024

Transitions of care from #hospital have long been associated with a #highrisk of #medicationerrors and #adverseevents. Time for a #stewardship approach? australianprescriber.tg.org.… @ManyaAngley @elliott_rohan @ShaniaLiu_ @Deequm

Rohan Elliott avatar
⟳ Manya Angley retweeted
Rohan Elliott@elliott_rohan·23 Aug 2024

Time for a medicines stewardship approach to transitions-of-care, to address the intractable problem of medication errors and harms following hospital discharge. Editorial with @ManyaAngley @Deequm @JonPenm @ShaniaLiu_ australianprescriber.tg.org.…

Australian Prescriber avatar
⟳ Manya Angley retweeted
Australian Prescriber@AustPrescriber·19 Aug 2024

New journal issue release! The August issue of #AustralianPrescriber highlights the pharmacological management of polycystic ovary syndrome, safe medication management during transitions of care, a judicious approach to investigations for inflammatory arthritis, and more. Plus, stay informed with our commentary on new drugs. Check out the August issue now! bit.ly/3WOQ7b2

Post attachment